KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)Dividends Paid - Common Growth (1y)Dividends Paid - Common Growth (3y)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)FCF Payout Ratio Growth (1y)FCF Payout Ratio Growth (3y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Capital Employed Growth (1y)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)
Income Statement
Others
Ratios

Novartis Ag (NVS) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 43.66%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 11.49%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 8.59%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 3,250.86%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 22.98%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 4.00%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 5.75%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 6.17%
10 Gsk 88.34 Bn 83.66 Bn - 4.70%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 14.00%
Dec 31, 2024 -0.59%
Dec 31, 2023 -11.61%
Dec 31, 2022 -6.76%
Dec 31, 2021 -5.86%
Dec 31, 2020 20,538.33%
Dec 31, 2019 99.05%
Dec 31, 2018 -16,552.63%
Dec 31, 2017 99.30%
Jun 30, 2010 60.00%
Mar 31, 2010 -233.33%